List of Tables
Table 1. Global Generic and Biosimilar Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Vaccines
Table 7. Key Players of Other
Table 8. Global Generic and Biosimilar Pharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Generic and Biosimilar Pharmaceuticals Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Generic and Biosimilar Pharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions (2016-2021)
Table 12. Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions (2022-2027)
Table 14. Generic and Biosimilar Pharmaceuticals Market Trends
Table 15. Generic and Biosimilar Pharmaceuticals Market Drivers
Table 16. Generic and Biosimilar Pharmaceuticals Market Challenges
Table 17. Generic and Biosimilar Pharmaceuticals Market Restraints
Table 18. Ranking of Global Top Generic and Biosimilar Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 19. Global Generic and Biosimilar Pharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Generic and Biosimilar Pharmaceuticals Market Share by Players (2016-2021)
Table 21. Global Top Generic and Biosimilar Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic and Biosimilar Pharmaceuticals as of 2020)
Table 22. Global 5 Largest Players Market Share by Generic and Biosimilar Pharmaceuticals Revenue (CR5 and HHI) (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Generic and Biosimilar Pharmaceuticals Product Solution and Service
Table 25. Date of Enter into Generic and Biosimilar Pharmaceuticals Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2021) & (US$ Million)
Table 28. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Type (2016-2021)
Table 29. Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 30. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Type (2022-2027)
Table 31. Global Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2021) & (US$ Million)
Table 32. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Application (2016-2021)
Table 33. Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 34. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Application (2022-2027)
Table 35. Key Players Generic and Biosimilar Pharmaceuticals Revenue in North America (2020-2021) (US$ Million)
Table 36. North America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million)
Table 37. North America Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2016-2021)
Table 38. North America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million)
Table 39. North America Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2022-2027)
Table 40. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021)
Table 41. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027)
Table 42. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021)
Table 43. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027)
Table 44. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)
Table 45. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)
Table 46. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)
Table 47. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)
Table 48. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Europe (2020-2021) (US$ Million)
Table 49. Europe Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million)
Table 50. Europe Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2016-2021)
Table 51. Europe Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million)
Table 52. Europe Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2022-2027)
Table 53. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)
Table 54. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)
Table 55. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)
Table 56. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)
Table 57. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Type (2016-2021)
Table 58. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Type (2022-2027)
Table 59. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Application (2016-2021)
Table 60. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Application (2022-2027)
Table 61. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)
Table 62. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)
Table 63. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)
Table 64. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)
Table 65. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)
Table 66. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)
Table 67. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)
Table 68. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)
Table 69. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)
Table 70. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)
Table 71. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)
Table 72. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)
Table 73. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Asia-Pacific (2020-2021) (US$ Million)
Table 74. Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
Table 75. Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size by Regions (2022-2027) & (US$ Million)
Table 76. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Type (2016-2021)
Table 77. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Type (2022-2027)
Table 78. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Application (2016-2021)
Table 79. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Application (2022-2027)
Table 80. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)
Table 81. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)
Table 82. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)
Table 83. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)
Table 84. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)
Table 85. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)
Table 86. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)
Table 87. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)
Table 88. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Type (2016-2021)
Table 89. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Type (2022-2027)
Table 90. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Application (2016-2021)
Table 91. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Application (2022-2027)
Table 92. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)
Table 93. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)
Table 94. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)
Table 95. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)
Table 96. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021)
Table 97. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027)
Table 98. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021)
Table 99. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027)
Table 100. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)
Table 101. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)
Table 102. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)
Table 103. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)
Table 104. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Latin America (2020-2021) (US$ Million)
Table 105. Latin America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million)
Table 106. Latin America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million)
Table 107. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)
Table 108. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)
Table 109. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)
Table 110. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)
Table 111. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)
Table 112. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)
Table 113. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)
Table 114. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)
Table 115. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)
Table 116. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)
Table 117. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)
Table 118. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)
Table 119. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Middle East & Africa (2020-2021) (US$ Million)
Table 120. Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million)
Table 121. Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million)
Table 122. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)
Table 123. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)
Table 124. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)
Table 125. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)
Table 126. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)
Table 127. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)
Table 128. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)
Table 129. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)
Table 130. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)
Table 131. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)
Table 132. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)
Table 133. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)
Table 134. Roche Company Details
Table 135. Roche Business Overview
Table 136. Roche Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 137. Roche Generic and Biosimilar Pharmaceuticals Generic and Biosimilar Pharmaceuticals Product
Table 138. Roche Recent Development
Table 139. Amgen Company Details
Table 140. Amgen Business Overview
Table 141. Amgen Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 142. Amgen Generic and Biosimilar Pharmaceuticals Product
Table 143. Amgen Recent Development
Table 144. AbbVie Company Details
Table 145. AbbVie Business Overview
Table 146. AbbVie Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 147. AbbVie Generic and Biosimilar Pharmaceuticals Product
Table 148. AbbVie Recent Development
Table 149. Sanofi-Aventis Company Details
Table 150. Sanofi-Aventis Business Overview
Table 151. Sanofi-Aventis Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 152. Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Product
Table 153. Sanofi-Aventis Recent Development
Table 154. Johnson & Johnson Company Details
Table 155. Johnson & Johnson Business Overview
Table 156. Johnson & Johnson Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 157. Johnson & Johnson Generic and Biosimilar Pharmaceuticals Product
Table 158. Johnson & Johnson Recent Development
Table 159. Pfizer Company Details
Table 160. Pfizer Business Overview
Table 161. Pfizer Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 162. Pfizer Generic and Biosimilar Pharmaceuticals Product
Table 163. Pfizer Recent Development
Table 164. Novo Nordisk Company Details
Table 165. Novo Nordisk Business Overview
Table 166. Novo Nordisk Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 167. Novo Nordisk Generic and Biosimilar Pharmaceuticals Product
Table 168. Novo Nordisk Recent Development
Table 169. Eli Lilly Company Details
Table 170. Eli Lilly Business Overview
Table 171. Eli Lilly Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 172. Eli Lilly Generic and Biosimilar Pharmaceuticals Product
Table 173. Eli Lilly Recent Development
Table 174. Novartis Company Details
Table 175. Novartis Business Overview
Table 176. Novartis Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 177. Novartis Generic and Biosimilar Pharmaceuticals Product
Table 178. Novartis Recent Development
Table 179. Merck Company Details
Table 180. Merck Business Overview
Table 181. Merck Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 182. Merck Generic and Biosimilar Pharmaceuticals Product
Table 183. Merck Recent Development
Table 184. 3sbio Company Details
Table 185. 3sbio Business Overview
Table 186. 3sbio Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 187. 3sbio Generic and Biosimilar Pharmaceuticals Product
Table 188. 3sbio Recent Development
Table 189. Changchun High Tech Company Details
Table 190. Changchun High Tech Business Overview
Table 191. Changchun High Tech Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 192. Changchun High Tech Generic and Biosimilar Pharmaceuticals Product
Table 193. Changchun High Tech Recent Development
Table 194. CP Guojian Company Details
Table 195. CP Guojian Business Overview
Table 196. CP Guojian Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 197. CP Guojian Generic and Biosimilar Pharmaceuticals Product
Table 198. CP Guojian Recent Development
Table 199. Biotech Company Details
Table 200. Biotech Business Overview
Table 201. Biotech Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 202. Biotech Generic and Biosimilar Pharmaceuticals Product
Table 203. Biotech Recent Development
Table 204. Gelgen Company Details
Table 205. Gelgen Business Overview
Table 206. Gelgen Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 207. Gelgen Generic and Biosimilar Pharmaceuticals Product
Table 208. Gelgen Recent Development
Table 209. Innovent Company Details
Table 210. Innovent Business Overview
Table 211. Innovent Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 212. Innovent Generic and Biosimilar Pharmaceuticals Product
Table 213. Innovent Recent Development
Table 214. Dong Bao Company Details
Table 215. Dong Bao Business Overview
Table 216. Dong Bao Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 217. Dong Bao Generic and Biosimilar Pharmaceuticals Product
Table 218. Dong Bao Recent Development
Table 219. Ganlee Company Details
Table 220. Ganlee Business Overview
Table 221. Ganlee Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 222. Ganlee Generic and Biosimilar Pharmaceuticals Product
Table 223. Ganlee Recent Development
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic and Biosimilar Pharmaceuticals Market Share by Type: 2020 & 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Erythropoietin Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Other Features
Figure 8. Global Generic and Biosimilar Pharmaceuticals Market Share by Application: 2020 & 2027
Figure 9. Tumor Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Cardiovascular Case Studies
Figure 12. Hemophilia Case Studies
Figure 13. Other Case Studies
Figure 14. Generic and Biosimilar Pharmaceuticals Report Years Considered
Figure 15. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions: 2016 VS 2021 VS 2027
Figure 16. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth 2016-2027 (US$ Million)
Figure 17. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions (2022-2027)
Figure 18. Global Generic and Biosimilar Pharmaceuticals Market Share by Players in 2020
Figure 19. Global Top Generic and Biosimilar Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic and Biosimilar Pharmaceuticals as of 2020)
Figure 20. The Top 10 and 5 Players Market Share by Generic and Biosimilar Pharmaceuticals Revenue in 2020
Figure 21. North America Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. U.S. Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Germany Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. France Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. U.K. Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Italy Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Russia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. China Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Japan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. South Korea Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. India Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Australia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Taiwan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Indonesia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Thailand Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Malaysia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Philippines Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Vietnam Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Latin America Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Mexico Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Brazil Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Argentina Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Turkey Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. UAE Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed